You are now leaving helsinn.com

Please click 'Continue to external site' if you want to continue.

Our Management Team

Our Management Team brings together wide-ranging expertise from across the whole of cancer care and rare diseases through product development of therapies through to commercialization products. We’re focused on pushing further to deliver more life-changing treatments for people with cancer today and in the future.

Helsinn’s Senior Executive Committee Team

Riccardo Braglia

Helsinn Group’s Vice Chairman and CEO

Giorgio Calderari

Group General Manager, COO & Board Member

Konrad Wilson

Group Chief Financial Officer

Georg Büchner

Group Chief Business Officer

Sergio Cantoreggi

Group Chief Scientific Officer, Global Head of R&D

Matteo Missaglia

Group General Counsel, Group Chief Legal Officer

Roberta Cannella

Group Chief Manufacturing Officer

Helsinn's Management Team

Waldo Mossi

Local General Manager, Helsinn Advanced Synthesis SA, Switzerland

Cristina Marenzi

Group Head of Human Resources

Paul Rittman

Local CEO, Helsinn Therapeutics (U.S.), Inc., USA

Matteo Santi

Group Compliance Officer and Group Head of Compliance and Quality

Enrico Magnani

Local General Manager, Helsinn Pharmaceuticals (Beijing) Co., Ltd., P.R.C.

Roberto Lazari

Group Head of Information and Communications Technology

Deirdre Hurley

Local General Manager, Helsinn Birex Pharmaceuticals Ltd., Ireland

Andrea Pontiggia

Group Head of Intl. Commercial Business